Zhao, Q., Jiang, Y., Xiang, S., Kaboli, P. J., Shen, J., Zhao, Y., . . . Xiao, Z. (2021). Engineered TCR-T Cell Immunotherapy in Anticancer Precision Medicine: Pros and Cons. Front Immunol.
Citación estilo ChicagoZhao, Qijie, et al. "Engineered TCR-T Cell Immunotherapy in Anticancer Precision Medicine: Pros and Cons." Front Immunol 2021.
Cita MLAZhao, Qijie, et al. "Engineered TCR-T Cell Immunotherapy in Anticancer Precision Medicine: Pros and Cons." Front Immunol 2021.
Precaución: Estas citas no son 100% exactas.